Work

Inhibition of c-ABL sensitizes breast cancer cells to the dual ErbB receptor tyrosine kinase inhibitor lapatinib (GW572016).

Year: 2011

Type: article

Source: PubMed

Authors: Yuan-Hung Lo, Po-Chun Ho, Huajun Zhao, Shao-Chun Wang

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Award: Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease

OpenAlex ID: W2418580632

FWCI: 0.811

Cites: 16

Cited by: 17

Related to: 10